PubRank

E Blume

Author PubWeight™ 8.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Determination of specific radioactivities of mononucleotides and glycolytic intermediates from mouse liver after labelling in vivo with [32P]orthophosphate. Eur J Biochem 1968 0.89
2 Sound, shock waves shatter kidney stones. JAMA 1983 0.81
3 Time of truth for cancer vaccines. J Natl Cancer Inst 1994 0.78
4 Premenstrual syndromes, depression linked. JAMA 1983 0.77
5 Hippocratic oath versus managed care: physicians caught in ethical squeeze. J Natl Cancer Inst 1997 0.77
6 Glycosylphosphatidylinositol-specific phospholipase D of human serum--activity modulation by naturally occurring amphiphiles. Biol Chem 2000 0.77
7 Researchers gain footholds in the cell cycle. J Natl Cancer Inst 1995 0.77
8 Investigators seek to increase taxol supply. J Natl Cancer Inst 1989 0.77
9 Sex after chemo: a neglected issue. J Natl Cancer Inst 1993 0.77
10 Street drugs yield primate Parkinson's model. JAMA 1983 0.76
11 A switch in time saves a statistical bind. JAMA 1991 0.75
12 Keeping cells in their place: the role of tumor suppressor genes. J Natl Cancer Inst 1989 0.75
13 Tumor virologists' reunion recalls century of research. J Natl Cancer Inst 1992 0.75
14 1971-1991: virus cancer research pays rich dividends. J Natl Cancer Inst 1991 0.75
15 FDA approval is not the end: getting the most out of taxol. J Natl Cancer Inst 1993 0.75
16 Secondary leukemias receive increased attention. J Natl Cancer Inst 1995 0.75
17 Gene therapy centers poised to proliferate. J Natl Cancer Inst 1994 0.75
18 Panel concludes ovarian cancer screening benefit unproven. J Natl Cancer Inst 1994 0.75
19 NCI scientist "temping" in top genome post. J Natl Cancer Inst 1992 0.75
20 p53: how a tumor suppressor works. J Natl Cancer Inst 1991 0.75
21 Drug designers target Ras for cancer treatment. J Natl Cancer Inst 1993 0.75
22 Amnesic patients give clues on structure of memory. JAMA 1983 0.75
23 Cefamandole concentrations in pulmonary and subcutaneous tissue. J Antimicrob Chemother 1979 0.75
24 Elderly patient needs assessment, not neglect. JAMA 1983 0.75
25 NIH launches human genome effort. J Natl Cancer Inst 1988 0.75
26 Gene transfer trial approved. J Natl Cancer Inst 1989 0.75
27 Smoking control effort moves to second phase. J Natl Cancer Inst 1993 0.75
28 Scientists adapt to loss of mice at Jackson Lab. J Natl Cancer Inst 1989 0.75
29 A review: new discoveries allow oncogenes to reclaim limelight. J Natl Cancer Inst 1989 0.75
30 Hormone replacement therapy: some answers ... more questions. J Natl Cancer Inst 1992 0.75
31 Cancer vaccines: researchers seek to turn promise into practice. J Natl Cancer Inst 1990 0.75
32 AACR president assesses state of cancer research. J Natl Cancer Inst 1994 0.75
33 Twenty years of progress in immunology research is ready for harvest. J Natl Cancer Inst 1991 0.75
34 The trials of olestra: is a fat-free lunch too costly? J Natl Cancer Inst 1995 0.75
35 Promising agents for limiting renal damage. JAMA 1983 0.75
36 Too many breast biopsies? Watching vs. cutting. J Natl Cancer Inst 1991 0.75
37 Experts call for full coordination of cancer effort, increased access to care. J Natl Cancer Inst 1994 0.75
38 Ambulatory dialysis: special boon for children. JAMA 1983 0.75
39 Collins takes helm of NIH genome project. J Natl Cancer Inst 1993 0.75
40 Scientists gain insight into cancer gene relationships. J Natl Cancer Inst 1993 0.75
41 Experts mull testing guidelines for family cancers. J Natl Cancer Inst 1991 0.75
42 'Tricks' of trade aid kidney transplants. JAMA 1983 0.75
43 Oncogene links seen to heart disease, cholesterol. J Natl Cancer Inst 1989 0.75
44 More patients to receive taxol. J Natl Cancer Inst 1992 0.75
45 When molecules tell tales, cancer researchers listen. J Natl Cancer Inst 1994 0.75
46 Perspective: what makes a cell run wild? J Natl Cancer Inst 1989 0.75
47 Scientists, activists discuss DES issues. J Natl Cancer Inst 1992 0.75
48 Agreement to develop Taxotere expected in April. J Natl Cancer Inst 1992 0.75
49 Cancer genes pose new dilemmas. J Natl Cancer Inst 1994 0.75
50 Researchers getting tough with pain. J Natl Cancer Inst 1994 0.75
51 Palliation may block cure of incontinence in elderly. JAMA 1983 0.75
52 Government moves to increase taxol supply. J Natl Cancer Inst 1991 0.75
53 Hormone replacement grows; some experts worried. J Natl Cancer Inst 1996 0.75
54 Investigators, insurers consider marrow transplant issues. J Natl Cancer Inst 1991 0.75
55 New clinical trials under way for DCIS. J Natl Cancer Inst 1997 0.75
56 Doctors strive to minimize DCIS treatment. J Natl Cancer Inst 1997 0.75
57 Dangers seen in increased treatment of elderly. J Natl Cancer Inst 1992 0.75
58 Gel chromatographic characterization of the hydrophobic interaction of glycosylphosphatidylinositol-alkaline phosphatase with detergents. Biol Chem 2000 0.75
59 Cutting edge meets clinic in treatment research. J Natl Cancer Inst 1994 0.75
60 1971-1991: molecular oncology comes into its own. J Natl Cancer Inst 1991 0.75
61 Wing of fly, gene of worm: unusual models shed light on cancer. J Natl Cancer Inst 1993 0.75
62 NCI awards Jackson Lab $9.5 million to rebuild. J Natl Cancer Inst 1990 0.75